Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
12/30/2004 | US20040266777 Pyridopyrazines and the use thereof as kinase inhibitors |
12/30/2004 | US20040266762 Indole derivatives having an apoptosis-inducing effect |
12/30/2004 | US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
12/30/2004 | US20040266757 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
12/30/2004 | US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
12/30/2004 | US20040265634 Device containing green organic light-emitting diode |
12/30/2004 | US20040265628 Organic luminescent compounds and methods of making and using same |
12/30/2004 | US20040265626 hole blocking layer containing a bathophenanthroline compound |
12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
12/29/2004 | WO2004113362A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
12/29/2004 | WO2004113357A2 Nucleoside analog inhibitors of reverse transcriptase |
12/29/2004 | WO2004113340A1 Novel imidazopyridine compound iii with therapeutic effect |
12/29/2004 | WO2004113339A1 Novel imidazopyridine compound ii with therapeutic effect |
12/29/2004 | WO2004113338A1 Novel imidazopyridine compound i with therapeutic effect |
12/29/2004 | WO2004113337A1 Convergent synthesis of a garft inhibitor containing a methyl substitute thiophene core and a tetrahydropyrido`2,3-d! pyrimidine ring system and intermediates therefor |
12/29/2004 | WO2004113336A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
12/29/2004 | WO2004113335A2 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
12/29/2004 | WO2004113323A1 Quinolyl amide derivatives as ccr-5 antagonists |
12/29/2004 | WO2004113303A1 INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF |
12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
12/29/2004 | WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
12/29/2004 | EP1491543A1 Intermediate compounds |
12/29/2004 | EP1491542A2 Intermediate compounds |
12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1490367A1 Imidazopyridine derivatives as kinase inhibitors |
12/29/2004 | EP1490366A1 Novel alkoxypyridine-derivatives |
12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
12/29/2004 | EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
12/29/2004 | EP1490363A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
12/29/2004 | EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
12/29/2004 | EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b |
12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/29/2004 | EP1373259B1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1226138B1 Fab i inhibitors |
12/29/2004 | EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
12/29/2004 | EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof |
12/29/2004 | EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists |
12/29/2004 | EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
12/29/2004 | EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase |
12/29/2004 | EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives |
12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
12/29/2004 | CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer |
12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
12/29/2004 | CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
12/29/2004 | CN1182136C Novel pyrrolo-(3,4-B) quinoline derivatives, method for prodn. and use thereof as medicament |
12/29/2004 | CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same |
12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
12/29/2004 | CA2533480A1 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
12/29/2004 | CA2530181A1 Novel imidazopyridine compound ii with therapeutic effect |
12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
12/29/2004 | CA2529161A1 Quinolyl amide derivatives as ccr-5 antagonists |
12/29/2004 | CA2528771A1 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
12/29/2004 | CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
12/28/2004 | US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
12/28/2004 | US6835738 Phenylalanine enamide derivatives |
12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
12/28/2004 | US6835736 Discorhabdin compounds and methods of use |
12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
12/28/2004 | US6835730 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof |
12/28/2004 | US6835728 Drug combination for the treatment of depression and related disorders comprising mirtazapine |
12/28/2004 | US6835727 Bone disorders; osteoporosis; rheumatic diseases |
12/28/2004 | US6835216 Chain-breaking antioxidants |
12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
12/23/2004 | WO2004111055A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
12/23/2004 | WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr) |
12/23/2004 | WO2004111051A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
12/23/2004 | WO2004111048A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
12/23/2004 | WO2004111047A2 Cycloalkanepyrrolopyridines as dp receptor antagonists |
12/23/2004 | WO2004111037A1 Cyclic tertiary amine compound |
12/23/2004 | WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
12/23/2004 | WO2004110996A1 Nk1 antagonist |
12/23/2004 | WO2004110992A2 Process for imidazo[4,5-c] pyridin-4-amines |
12/23/2004 | WO2004110991A2 PROCESS FOR IMIDAZO[4,5-c]PYRIDIN-4-AMINES |
12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
12/23/2004 | WO2004110364A2 Thiotungstate analogues and uses thereof |
12/23/2004 | WO2004091518A3 Cxcr4 chemokine receptor binding compounds |
12/23/2004 | WO2004089380A3 Pharmaceutical use of fused 1,2,4-triazoles |
12/23/2004 | WO2004083215A9 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
12/23/2004 | WO2004076411A3 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
12/23/2004 | WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
12/23/2004 | WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists |
12/23/2004 | US20040260085 Oriented amphiphilic molecules and macrocyclic modules from organic synthons R,R-1,2-transdiaminocyclohexane and 4-substituted 2,6-diformyl phenol; dialysis membranes with improved sodium, potassium and chloride ion permselectivity in water |
12/23/2004 | US20040259903 Pyrido [2,1-a] isoquinoline derivatives |
12/23/2004 | US20040259902 Dipeptidyl aminopeptidase inhibitors; antidiabetic agents for type 2 diabetes; 2-amino-3-(substituted phenyl-, pyridyl- or pyrrolyl-)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline compounds |
12/23/2004 | US20040259896 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
12/23/2004 | US20040259870 Antidiabetic agents; obesity; controlling appetite |
12/23/2004 | US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists |
12/23/2004 | US20040259826 Mitotic kinesin inhibitors |
12/23/2004 | DE19549741B4 Verwendung von Phenanthren-Derivaten in flüssigkristallinen Mischungen Use of phenanthrene derivatives in liquid-crystalline mixtures |
12/23/2004 | CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
12/23/2004 | CA2528929A1 Cyclic tertiary amine compound |
12/23/2004 | CA2528652A1 Nk1 antagonist |